We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Lundbeck Loses U.K. Patent Case Over Cipralex

Law360 (May 7, 2007, 12:00 AM EDT) -- Danish pharmaceutical company H. Lundbeck A/S suffered a blow Friday when a British court ruled against it in a dispute with three generic makers over a patent for its top-selling antidepressant drug, Cipralex.

The three generic companies, Teva Pharmaceuticals Ltd., Generics (UK) Ltd. and Arrow Generics Ltd., filed separate complaints alleging that certain claims in Lundbeck’s Cipralex patent were invalid because they were obvious, not novel because of prior art and insufficient. The United Kingdom’s High Court of Justice’s Patent Court combined the three claims into...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.